Bristol-Myers Squibb 

€48.6
8720
+€0.6+1.25% Friday 06:04

Statistics

Day High
48.6
Day Low
48.6
52W High
53.34
52W Low
36.79
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
4.49%
Dividend
2.18

Upcoming

Dividends

4.49%Dividend Yield
May 26
€0.55
Feb 26
€0.54
Nov 25
€0.53
Aug 25
€0.53
May 25
€0.57
10Y Growth
7.9%
5Y Growth
11.63%
3Y Growth
0.74%
1Y Growth
-2.09%

Earnings

30JulExpected
Q4 2025
Q1 2026
Next
1.04
1.16
1.27
1.39
Expected EPS
1.3858202819699998
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BRM.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap146.36B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap275.09B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap532.77B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap356.49B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap101.2B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap278.64B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap179.12B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap103.76B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap329.06B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap283.47B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

There is no Profile data available for BRM.SG.
Show more...
CEO
Country
United States
ISIN
US1101221083

Listings

0 Comments

Share your thoughts

FAQ

What is Bristol-Myers Squibb stock price today?
The current price of BRM.MU is €48.6 EUR — it has increased by +1.25% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Bristol-Myers Squibb stocks are traded under the ticker BRM.MU.
Is Bristol-Myers Squibb stock price growing?
BRM.MU stock has risen by +1% compared to the previous week, the month change is a -2.42% fall, over the last year Bristol-Myers Squibb has showed a +19.47% increase.
When is the next Bristol-Myers Squibb earnings date?
Bristol-Myers Squibb is going to release the next earnings report on July 30, 2026.
What were Bristol-Myers Squibb earnings last quarter?
BRM.MU earnings for the last quarter are 1.35 EUR per share, whereas the estimation was 1.21 EUR resulting in a +10.99% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Bristol-Myers Squibb pay dividends?
Yes, BRM.MU dividends are paid quarterly. The last dividend per share was 0.55 EUR. As of today, Dividend Yield (FWD)% is 4.49%.
In which sector is Bristol-Myers Squibb located?
Bristol-Myers Squibb operates in the Materials sector.
When did Bristol-Myers Squibb complete a stock split?
Bristol-Myers Squibb has not had any recent stock splits.